Do patient characteristics matter when calculating sample size for eczema clinical trials?
Abstract Background The Patient‐Oriented Eczema Measure (POEM) is the core outcome instrument recommended for measuring patient‐reported atopic eczema symptoms in clinical trials. To ensure that the statistical significance of clinical trial results is meaningful, trials are often designed by specif...
| Published in: | Skin Health and Disease |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Oxford University Press
2021-09-01
|
| Online Access: | https://doi.org/10.1002/ski2.42 |
